Statistics on Biotechnology Use  
Results by fields of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1.233,740,405,89,
%Companies according to biotechnology used: Genetic code,31,7,41,6,15,1,24,8,
%Companies according to biotechnology used: Functional units,38,5,43,6,32,2,25,2,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,22,8,27,7,14,6,19,
%Companies according to biotechnology used: Bioprocesses,53,4,43,1,76,8,32,3,
%Companies according to biotechnology used: Sub-cellular organisms,8,6,11,9,4,6,0,
%Companies according to biotechnology used: Bio-computing,22,3,31,9,6,7,1,
%Companies according to biotechnology used: Nanobiotechnology,10,6,13,8,6,9,1,1,
%Companies according to biotechnology used: Other,14,2,15,7,7,6,31,7,
Companies in which biotechnology activities are: Main and/or exclusive,615,485,113,17,
Companies in which biotechnology activities are: A secondary line of business,178,85,79,15,
Companies in which biotechnology activities are: A tool necessary for production,440,170,213,57,
%Company by field(s) of ultimate application of biotechnology use: Human Health,46,3,63,5,24,4,2,3,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,16,2,17,8,11,8,23,5,
%Company by field(s) of ultimate application of biotechnology use: Food products,32,22,4,50,30,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,24,6,23,1,18,7,63,4,
%Company by field(s) of ultimate application of biotechnology use: Environment,15,5,15,15,5,19,7,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,9,13,5,14,1,2,3,
Personnel in R&D in biotechnology (no. of persons),13.444,8.462,4.143,840,
Personnel in R&D in biotechnology (no. of persons): Researchers,7.378,5.167,1.974,237,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,6.066,3.295,2.169,603,
Personnel in R&D in biotechnology (no. of persons): women,7.501,4.900,2.238,363,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,4.052,2.875,1.070,106,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,3.450,2.025,1.168,257,
Personnel in R&D in biotechnology (FTE),9.401,9,5.991,3,2.869,8,540,9,
Personnel in R&D in biotechnology (FTE): Researchers,5.398,3,3.774,1,1.455,1,169,2,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,4.003,6,2.217,2,1.414,7,371,7,
Personnel in R&D in biotechnology (FTE): women,5.426,2,3.510,7,1.654,8,260,7,
Personnel in R&D in biotechnology (FTE): (women) Researchers,3.016,4,2.104,1,830,3,82,1,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,2.409,8,1.406,6,824,5,178,7,
Internal expenditure on R&D (thousands of euros),897.333,545.374,308.398,43.561,
1) By nature of the expense: Current expenses,817.409,495.422,283.561,38.426,
1.1) Remuneration to researchers,295.705,177.158,109.976,8.570,
1.2) Remuneration to technicians and assistants,156.853,84.448,62.043,10.362,
1.3) Other current expenses,364.852,233.816,111.542,19.494,
2) By nature of the expense: Capital expenses,79.924,49.952,24.837,5.135,
2.1) Land and buildings,10.272,5.381,2.529,2.362,
2.2) Equipment and instruments,56.609,35.410,19.076,2.123,
2.3) Acquisition of specific R&D software,4.839,2.768,1.974,97,
2.4) Otros productos de propiedad intelectual específicos para I+D,8.203,6.393,1.257,552,
1.1) By origin of the funds: Own funds,613.097,312.617,260.467,40.014,
1.2) By origin of the funds: From companies,86.085,76.374,9.711,0,
1.3) By origin of the funds: Public Administration funds,92.140,79.925,10.827,1.388,
1.4) By origin of the funds: From Universities,853,853,0,0,
1.5) By origin of the funds: From non profit private institutions,4.682,4.682,0,0,
1.6) By origin of the funds: Foreign funds,100.476,70.924,27.393,2.159,
Purchase of R&D services in biotechnology (thousands of euros),85.011,43.595,40.577,839,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,54.243,18.614,34.957,672,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,30.768,24.981,5.620,168,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,39,2,49,7,23,8,22,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,11,7,11,7,11,5,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,12,5,13,6,10,5,12,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,10,9,11,8,9,1,11,3,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,14,3,17,6,8,5,13,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,16,5,20,8,9,3,13,6,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,15,17,7,9,7,17,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,36,40,30,32,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,46,7,50,9,39,7,43,2,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,21,6,14,2,19,5,
% Companies that have requested biotechnology patents in Biotechnology,17,3,22,1,10,4,9,4,
Number of patents requested,681,528,119,34,
% Companies with income of an international origin related to biotechnological activities,23,25,3,22,1,8,6,
% Turnover representing income of an international origin related to biotechnological activities,1,6,5,1,1,3,1,2,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,55,9,30,1,65,4,78,2,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,44,1,69,9,34,6,21,8,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,83,9,93,7,79,9,90,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,14,7,2,20,0,
% Income of an international origin related with activities according to the classification: Operating source abroad,0,8,2,7,0,0,
% Income of an international origin related with activities according to the classification: Other,0,6,1,5,0,10,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute